The content on this site is intended for healthcare professionals only
Dr Verena Hoffmann presents, at a press conference at EHA 2015, on a web-based registry to record all newly-diagnosed CML patients in 20 European countries or pre-specified regions covering overall 92.5 million inhabitants.
Read the news story for more.
Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma
New classification for identifying HR myeloma based on cytogenetic abnormalities
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Advancements in paediatric Acute lymphoblastic leukemia management
Multiple myeloma In Rwanda: The need for further research
A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM
